Clinical trial
Dextromethorphan to Treat Patients With Voice Spasms
NCT00055549 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00055549 |
|---|---|
| Title | Dextromethorphan to Treat Patients With Voice Spasms |
| Official title | The Effects of an NMDA-Receptor Antagonist in Idiopathic Voice Disorders |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Voice Disorders |
| Intervention type | Drug |
| Interventions | Dextromethorphan, Lorazepam |
| Enrollment | 65 |
| Start date | Mar 4, 2003 |
| Primary completion | Nov 13, 2009 |
| Completion | Nov 13, 2009 |
| First posted | Mar 5, 2003 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: